H.R. 5926 — Introduced in House

I 115th CONGRESS 2d Session H. R. 5926 IN THE HOUSE OF REPRESENTATIVES May 23, 2018Mr. Keating (for himself and Mr. Rothfus) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To require the Secretary of Health and Human Services to issue guidelines for prescribing naloxone, and for other purposes. 1. Short title This Act may be cited as the Naloxone Guidelines Act of 2018. 2. Guidelines for prescribing naloxone (a) In general Not later than 180 days after the date of the enactment of this Act, the Secretary of Health and Human Services shall issue guidelines for prescribing an opioid overdose reversal drug. (b) Contents In issuing guidelines under subsection (a), the Secretary shall address the following: (1) Co-prescribing an opioid overdose reversal drug in conjunction with any prescribed opioid. (2) Dosage safety. (3) Prescribing an opioid overdose reversal drug to an individual other than a patient. (4) Standing orders. (5) Other distribution, education, and safety measures as determined necessary.